Bayer completes recruitment of first cohort for BAY 86-6150 Stage II/III research in hemophilia Bayer's BAY 86-6150 has been investigated in a Stage II/III research called TRUST , and the recruitment of the initial cohort is currently complete. Recruitment can be ongoing at sites located around the global world, including in the U.S., where sites will be ready to enroll eligible individuals. Bayer is focused on finding innovative methods to meet the requirements of individuals with hemophilia, including those suffering from the consequences of inhibitors to clotting element replacement therapies, stated Pamela Cyrus, MD, Vice Head and President, U.S. Medical Affairs, Bayer HealthCare Pharmaceuticals..Relating to VOA News, Clinton will talk with President Umaru Yar’Adua Wednesday on the fifth stop of her Africa trip. Through the trip to Nigeria, Johnnie Carson, assistant secretary of state for African affairs, told reporters, Nigeria is without a doubt the most important country in sub-Saharan Africa, Reuters reports . Regarding to Agence France-Presse, Clinton will hold a roundtable dialogue with religious leaders. A senior U.S. Official, speaking on condition of anonymity, stated that Clinton would listen to the spiritual leaders but that her primary message would be on good governance and electoral reform .